StockCalc Blog

Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Adaptimmune Therapeutics(ADAP:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.04 (USD) 04/14/2021 Weighted Valuation$5.05 (USD) Overall RatingFairly valued to slightly Undervalued by 0.3% Valuation Models Comparables: $7.73 …

Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report Read more »

ADT (ADT:NYS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report ADT(ADT:NYS) Industrials:Security & Protection Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.32 (USD) 04/14/2021 Weighted Valuation$10.98 (USD) Overall RatingUndervalued by 17.8% Valuation Models Multiples: $9.14 (USD) …

ADT (ADT:NYS) Fundamental Valuation Report Read more »

American Electric Power (AEP:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report American Electric Power(AEP:NAS) Utilities:Utilities – Regulated Electric This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$87.07 (USD) 04/14/2021 Weighted Valuation$87.29 (USD) Overall RatingFairly valued to slightly Undervalued by …

American Electric Power (AEP:NAS) Fundamental Valuation Report Read more »

AES (AES:NYS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report AES(AES:NYS) Utilities:Utilities – Diversified This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$28.37 (USD) 04/14/2021 Weighted Valuation$30.33 (USD) Overall RatingUndervalued by 6.9% Valuation Models Comparables: $37.68 (USD) Valuation …

AES (AES:NYS) Fundamental Valuation Report Read more »

American Financial Group (AFG:NYS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report American Financial Group(AFG:NYS) Financial Services:Insurance – Property & Casualty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$119.07 (USD) 04/14/2021 Weighted Valuation$119.73 (USD) Overall RatingFairly valued …

American Financial Group (AFG:NYS) Fundamental Valuation Report Read more »

Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Agios Pharmaceuticals(AGIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$53.36 (USD) 04/14/2021 Weighted Valuation$58.00 (USD) Overall RatingUndervalued by 8.7% Valuation Models Comparables: $74.03 (USD) Multiples: $64.54 (USD) …

Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »

Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report

By admin Posted on April 15, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Akebia Therapeutics(AKBA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.12 (USD) 04/14/2021 Weighted Valuation$3.53 (USD) Overall RatingUndervalued by 13.4% Valuation Models Adjusted Book Value: $3.53 (USD) …

Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report Read more »

Top 20 Undervalued Stocks by Market Cap Class April 2021: Technology Sector

By Brian Donovan Posted on April 14, 2021 Posted in Undervalued Stocks No Comments

What are the top 20 Undervalued Stocks (selected over 5 market cap classes) in the Technology Sector? I have used the analysis tools on the website stockcalc.com to generate the content of this blog post. Have a look down the …

Top 20 Undervalued Stocks by Market Cap Class April 2021: Technology Sector Read more »

Independent Bank (INDB:NAS) Fundamental Valuation Report

By admin Posted on April 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Independent Bank(INDB:NAS) Financial Services:Banks – Regional This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$90.57 (USD) 03/19/2021 Weighted Valuation$89.93 (USD) Overall RatingFairly valued to slightly Overvalued by 0.7% …

Independent Bank (INDB:NAS) Fundamental Valuation Report Read more »

Summit Hotel Properties (INN:NYS) Fundamental Valuation Report

By admin Posted on April 14, 2021 Posted in Fundamental Valuation Report

Valuation

Fundamental Valuation Report Summit Hotel Properties(INN:NYS) Real Estate:REIT – Hotel & Motel This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$10.76 (USD) 03/19/2021 Weighted Valuation$7.91 (USD) Overall RatingOvervalued by 26.5% …

Summit Hotel Properties (INN:NYS) Fundamental Valuation Report Read more »

Notice to User:

Risk Disclosure:
Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure:
Hypothetical performance results have many inherent limitations, some of which are described below. no representation is being made that any account will or is likely to achieve profits or losses similar to thoseshown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted forin the preparation of hypothetical performance results and all which can adversely affect trading results.

Live Trades Disclosure:
This presentation is for educational purposes only and the opinions expressed are those of the presenter only. All trades presented should be considered hypothetical and should not be expected to be replicated in a live trading account.